Price T Rowe Associates Inc Cabaletta Bio, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,187,039 shares of CABA stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,187,039
Previous 489,321
346.95%
Holding current value
$3.15 Million
Previous $678,000
390.41%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CABA
# of Institutions
94Shares Held
77.1MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$13.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$12.7 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$9.78 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$8.67 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$7.2 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $41.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...